MedPath

Cross-Sectional Survey on the Use of Tobacco Products - London (UK)

Terminated
Conditions
Tobacco Use
Interventions
Other: Survey on Use of Tobacco Products in the General Population
Other: Survey on Use of Tobacco Products in IQOS Users
Registration Number
NCT03527030
Lead Sponsor
Philip Morris Products S.A.
Brief Summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in London, United Kingdom.

The study was prematurely terminated after the first annual survey and was not be repeated due to the impossibility to recruit sufficient participants to meet the target sample size in the IQOS user sample.

Detailed Description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of the Greater London area and in adult IQOS users registered in the IQOS user database of Philip Morris Limited (UK IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:

1. Estimate the prevalence of current tobacco use status in the study population.

2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse).

3. Explore the association between self-reported health status and use of tobacco products in the study population.

4. Explore the association between patterns of IQOS use including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in the Greater London area registered in UK IQOS User Database.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
6116
Inclusion Criteria

Not provided

Exclusion Criteria
  • Not meeting the inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
General PopulationSurvey on Use of Tobacco Products in the General PopulationAdults living in a registered household in the Greater London area.
IQOS usersSurvey on Use of Tobacco Products in IQOS UsersAdult current IQOS users (at the time of survey) living in the Greater London area who are registered in the UK IQOS User Database and agree to be contacted for research purposes at the time of registration.
Primary Outcome Measures
NameTimeMethod
Self-reported health statusStudy duration (1 year).

Association between self-reported health status and use of tobacco products in the study population.

Perceived riskStudy duration (1 year).

Association between patterns of use with perceived risk.

IQOS use experienceStudy duration (1 year).

Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).

Prevalence of current tobacco useStudy duration (1 year).

Prevalence of current tobacco use status in the study population.

Past tobacco use statusStudy duration (1 year).

Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Philip Morris Products S.A.

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath